Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study
Alexis Trécourt(Hospices Civils de Lyon), Cécile de Chaisemartin, Chloé Broudin(Assistance Publique – Hôpitaux de Paris), Mojgan Devouassoux‐Shisheboran, Magali Svrcek(Centre Léon Bérard), Karine Abboud, Witold Gertych(Lyon 1 Université), Vahan Képénékian(Hospices Civils de Lyon), Aurélie Charissoux, Laurent Villeneuve(Université Claude Bernard Lyon 1), Olivier Gléhen(Hospices Civils de Lyon), Agnès Leroux(Délégation Centre-Est), Fatiha Bouhidel, J Coget, Valérie Boige(Inserm), Peggy Dartigues(Institut Gustave Roussy), Nazim Benzerdjeb(Université Claude Bernard Lyon 1), Kocéila Amroun(Centre Hospitalier de Valence), A Chevallier, Marilyn Augros(Centre Hospitalier de Valence), Catherine Genestie(Institut Gustave Roussy), Sixte Thierry(Centre Hospitalier de Valence), Frédéric Bibeau(Centre Hospitalier Universitaire de Besançon), Olivier Bouché(CHU Dijon Bourgogne), Houda Ben Rejeb, Thierry André(Inserm), A Bardier, C. Arvieux(Université Grenoble Alpes), Cécilia Ceribelli, Lakhdar Khellaf(Institut de Recherche en Cancérologie de Montpellier), Naoual Bakrin(Université Claude Bernard Lyon 1), Alhadeedi Omar(Amiri Hospital), Marie Dazza(Hospices Civils de Lyon), Thomas Courvoisier-Clément, Gerlinde Averous-Lang, Marie-Dominique Bouzard(Hospices Civils de Lyon), Philippe Bertheau(Sorbonne Université), Cécile Brigand, F. Quénet, Sylvie Isaac(Hospices Civils de Lyon), A Aimé, Pierre‐Emmanuel Bonnot(Centre Georges François Leclerc), J. Abba(Centre Hospitalier Universitaire de Grenoble), Juliette Fontaine(Hospices Civils de Lyon), Frédéric Marchal(Institut de Cancérologie de Lorraine), Jean-Marc Béréder, Bertrand Célérier, Elise Clément, Cécile Odin(Lyon 1 Université)
Cited by 8
Related Papers
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
|New England Journal of Medicine|2020|2.9k
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k